title: Is liposomal amphotericin B (ambisome) an effective prophylaxis of mycotic infections after liver transplantation?
authors.affiliation: Klinik für Transplantationschirurgie, Georg-August-Universität, Göttingen, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Braun
authors.forename: R
authors.initials: R
authors.lastname: Rüchel
authors.forename: T
authors.initials: T
authors.lastname: Lorf
authors.forename: R
authors.initials: R
authors.lastname: Canelo
authors.forename: A
authors.initials: A
authors.lastname: Müller
authors.forename: B
authors.initials: B
authors.lastname: Sattler
authors.forename: B
authors.initials: B
authors.lastname: Ringe
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008081:Liposomes; D016031:Liver Transplantation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000517:prevention & control*; D011183:Postoperative Complications
chemical_list: D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B